article thumbnail

Leveraging Sterile Compounding Technology and Removing Barriers to Improve Safety

Omnicell

And one of the highest areas of opportunity for human error is in the sterile compounding process. The guidelines recognize IV workflow management systems as the minimum safety standard for preparing compounded preparations and IV robotics are recommended for high volume, large batch preparations. savings per year.

article thumbnail

Elevating Sterile Compounding Accuracy

Omnicell

Terri Albarano, PharmD Director, Autonomous Pharmacy, Omnicell Sterile compounding safety is one of the biggest challenges for the pharmacy supply chain. Health systems are expected to compound IV preparations with increasingly complex regulations, rising drug costs, and supply disruptions. billion in associated costs.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Why IV Automation Is Critical for Sterile Compounding

Omnicell

Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell Imagine if Amazon lost one out of every 10 packages. So why, as clinicians, are we not focused on improving the documented one in 10 inaccuracies in sterile compounded products? Or the airlines lost 10% of passenger bags.

article thumbnail

Adopting Automation Supports Safer, More Efficient Sterile Compounding

Omnicell

Dennis Wright Senior Director, Central Pharmacy Dispensing Services, Omnicell As disruption and uncertainty in the supply of IV medications from outsourced compounding facilities continues, health system pharmacies should reevaluate how they are managing sterile compounding needs. 23 at 1 pm ET.

article thumbnail

Driving Safety and Savings Through System-Wide Sterile Compounding Automation

Omnicell

David Webster Director of Acute Care Pharmacy Operations, University of Rochester Medical Center Sterile compounding is one of the most high risk, high cost areas of medication management. Manual compounding is fraught with error, studies indicating 1 in 10 IVs are not prepared according to guidelines.

article thumbnail

Driving Pharmacy Value Through Robotics and Connected Technology

Omnicell

Dennis Wright, Senior Director, Product Marketing, Omnicell As health systems navigate escalating staff shortages and increasingly complex drug therapies, the need for a high-performing pharmacy has never been greater. Read more about the Omnicell-AHN Partnership in this week’s press release.

article thumbnail

IV Robotics and the Latest USP Revisions

Omnicell

The latest revisions, which take effect November 1, 2023, exempt some robotic devices from surface sampling after every batch of Category 3 compounded sterile products (CSPs) and instead allow users of self-enclosed robotic devices to surface sample once per day.